Berthe Aleman, MD, PhD

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL)
Amsterdam, Noord-Holl

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3333 - Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects

  Tuesday, October 1, 2024
  4:00 PM – 5:00 PM ET